Core Viewpoint - The company, 信铭生命科技 (00474), has acknowledged the findings of the Securities and Futures Commission (SFC) regarding its shareholding distribution as of December 31, 2025, highlighting significant ownership concentration among a few shareholders and a substantial increase in share price over a short period [1][5]. Group 1: Shareholding Structure - As of December 31, 2025, twenty shareholders and their associates collectively held 1.387 billion shares, representing 18.79% of the total issued shares [1][5]. - The three major shareholders owned 5.31 billion shares, accounting for 71.94% of the total issued shares, leading to a total of 90.73% of shares held by these major shareholders [1][5]. - Only 684 million shares, or 9.27% of the total issued shares, were held by other shareholders [1][5]. Group 2: Share Price Movement - The closing price of the shares increased by 489% from HKD 0.019 on September 10, 2025, to HKD 0.112 on December 31, 2025 [1][5]. - On January 12, 2026, the share price closed at HKD 0.118, reflecting a 521% increase compared to the closing price of HKD 0.019 on September 10, 2025 [1][5]. Group 3: Compliance with Listing Rules - The company confirmed that at least 25% of its issued shares were held by the public as of December 31, 2025, ensuring compliance with the public float requirements of the stock exchange [2][6].
信铭生命科技回应股权高度集中 称公司能遵守公众持股量规定